{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:35:14Z","timestamp":1792683314329,"version":"4.5.0"},"reference-count":29,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Low-dose aspirin is a cornerstone of cardiovascular prevention in high-risk patients, inhibiting platelet cyclooxygenase (COX-1) and reducing thromboxane A2 (TXA2) production for 24 hours. However, the duration of this effect varies among individuals, and the role of inflammation and platelet microRNAs in this variability remains unclear. This study identifies a thromboinflammatory mechanism linked to shorter duration of TXB2 suppression during aspirin therapy. This mechanism involves (1) elevated circulating S100A8\/A9, indicating systemic inflammation; (2) reduced platelet microRNA-21-5p (miR-21-5p) and increased circulating miR-21-5p (c\u2013miR-21-5p), suggesting altered microRNA regulation; (3) S100A8\/A9-driven upregulation of platelet multidrug resistance protein 4 (MRP4); and (4) enhanced COX-1 expression, resulting in increased TX production. Patients with accelerated COX-1 recovery had increased circulating S100A8\/A9 and platelet MRP4, directly related with serum TXB2 and platelet COX-1 mRNA\/protein levels. In vitro, recombinant S100A8\/A9 (rS100A8\/A9) upregulated MRP4 and COX-1 in platelets and DAMI, a human megakaryoblastic cell line, and MRP4 inhibition prevented this effect. Additionally, these patients exhibited lower platelet miR-21-5p levels and higher c\u2013miR-21-5p, inversely and directly related, respectively, to S100A8\/A9, MRP4, and serum TXB2 slope. In DAMI cells, rS100A8\/A9 reduced platelet miR-21-5p and increased c\u2013miR-21-5p, effects prevented by MRP4 inhibition. During immune inflammation, reflected by high circulating S100A8\/A9, once-daily aspirin may incompletely inhibit COX-1 due to miR-21-5p downregulation, higher megakaryocyte\/platelet MRP4 expression, COX-1 upregulation driving platelet activation, and c\u2013miR-21-5p release. Circulating S100A8\/A9 and miR-21-5p can serve as biomarkers for patients with shorter duration of aspirin effect over 24 hours and potential targets to optimize antiplatelet therapy for high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017653","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:08:30Z","timestamp":1764173310000},"page":"1236-1249","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Circulating S100A8\/A9 drives faster platelet COX-1 recovery via MRP4, impairing the duration of aspirin response"],"prefix":"10.1182","volume":"10","author":[{"given":"Rossella","family":"Liani","sequence":"first","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Giustina","family":"Simeone","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-3148","authenticated-orcid":false,"given":"Margherita","family":"Alfonsetti","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9273-2393","authenticated-orcid":false,"given":"Stefano","family":"Lattanzio","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ricci","sequence":"additional","affiliation":[{"name":"2Department of Pharmacy, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3951-3890","authenticated-orcid":false,"given":"Maurizio","family":"Frezza","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ciotti","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Luongo","sequence":"additional","affiliation":[{"name":"3Clinical Pathology of Chieti University Hospital, ASL 2 Abruzzo, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cipollone","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-396X","authenticated-orcid":false,"given":"Fabio","family":"Pulcinelli","sequence":"additional","affiliation":[{"name":"4Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Santilli","sequence":"additional","affiliation":[{"name":"1Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, \u201cG. d\u2019Annunzio\u201d University of Chieti Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"24","key":"2026022411372786800_bib1","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"issue":"15","key":"2026022411372786800_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/eurheartj\/ehad868","article-title":"Thromboxane biosynthesis and future events in diabetes: the ASCEND trial","volume":"45","author":"Petrucci","year":"2024","journal-title":"Eur Heart J"},{"issue":"27","key":"2026022411372786800_bib3","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/eurheartj\/ehae324","article-title":"Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease","volume":"45","author":"Patrono","year":"2024","journal-title":"Eur Heart J"},{"issue":"1","key":"2026022411372786800_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-024-03022-w","article-title":"Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital","volume":"58","author":"Galli","year":"2025","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"2026022411372786800_bib5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2026022411372786800_bib6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3324\/haematol.2022.281006","article-title":"Reduced platelet glycoprotein Ib\u03b1 shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen","volume":"108","author":"Simeone","year":"2023","journal-title":"Haematologica"},{"issue":"5","key":"2026022411372786800_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.RES.0000214553.37930.3e","article-title":"De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin","volume":"98","author":"Evangelista","year":"2006","journal-title":"Circ Res"},{"issue":"7","key":"2026022411372786800_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","article-title":"Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting","volume":"58","author":"Mattiello","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2026022411372786800_bib9","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3324\/haematol.2021.279761","article-title":"Specific inhibition of the transporter MRP4\/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets","volume":"107","author":"Wolf","year":"2022","journal-title":"Haematologica"},{"issue":"21","key":"2026022411372786800_bib10","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1182\/bloodadvances.2024014273","article-title":"Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction","volume":"8","author":"Benkhoff","year":"2024","journal-title":"Blood Adv"},{"issue":"5","key":"2026022411372786800_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.108.814582","article-title":"Myeloid-related protein-8\/14 is critical for the biological response to vascular injury","volume":"120","author":"Croce","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"2026022411372786800_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/rccm.200810-1552OC","article-title":"Expression and role of myeloid-related protein-14 in clinical and experimental sepsis","volume":"180","author":"van Zoelen","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"37","key":"2026022411372786800_bib13","doi-asserted-by":"crossref","first-page":"eabh2434","DOI":"10.1126\/sciadv.abh2434","article-title":"Platelets amplify endotheliopathy in COVID-19","volume":"7","author":"Barrett","year":"2021","journal-title":"Sci Adv"},{"issue":"2","key":"2026022411372786800_bib14","doi-asserted-by":"crossref","first-page":"100116","DOI":"10.1016\/j.rpth.2023.100116","article-title":"Novel mechanisms of thrombo-inflammation during infection: spotlight on neutrophil extracellular trap-mediated platelet activation","volume":"7","author":"Colicchia","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2026022411372786800_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/ATVBAHA.121.317113","article-title":"Neutrophil-derived protein S100A8\/A9 alters the platelet proteome in acute myocardial infarction and is associated with changes in platelet reactivity","volume":"42","author":"Joshi","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2026022411372786800_bib16","doi-asserted-by":"crossref","first-page":"e000903","DOI":"10.1161\/JAHA.114.000903","article-title":"Circulating myeloid-related protein-8\/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment","volume":"3","author":"Santilli","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2026022411372786800_bib17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/rth2.12104","article-title":"MiR-21 role in aspirin-dependent PPAR\u03b1 and multidrug resistance protein 4 upregulation","volume":"2","author":"Massimi","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2026022411372786800_bib18","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2003-12-4330","article-title":"The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage","volume":"104","author":"Jedlitschky","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2026022411372786800_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s44161-023-00289-9","article-title":"Structural insights into human ABCC4-mediated transport of platelet agonist and antagonist","volume":"2","author":"Chen","year":"2023","journal-title":"Nat Cardiovasc Res"},{"issue":"6","key":"2026022411372786800_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bcp.12432","article-title":"Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets","volume":"78","author":"Massimi","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2026022411372786800_bib21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.109.190314","article-title":"High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions","volume":"29","author":"Ionita","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2026022411372786800_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/eurheartj\/ehm078","article-title":"Myeloid-related protein 8\/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes","volume":"28","author":"Altwegg","year":"2007","journal-title":"Eur Heart J"},{"issue":"3","key":"2026022411372786800_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11239-020-02221-5","article-title":"Biomarkers of platelet activation and cardiovascular risk in the DAPT trial","volume":"51","author":"Berg","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"2026022411372786800_bib24","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI92450","article-title":"Neutrophil-derived S100 calcium-binding proteins A8\/A9 promote reticulated thrombocytosis and atherogenesis in diabetes","volume":"127","author":"Kraakman","year":"2017","journal-title":"J Clin Invest"},{"issue":"20","key":"2026022411372786800_bib25","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1182\/blood-2011-01-292011","article-title":"MicroRNAs in platelet production and activation","volume":"117","author":"Edelstein","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2026022411372786800_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41598-017-18985-5","article-title":"Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications","volume":"8","author":"Nassa","year":"2018","journal-title":"Sci Rep"},{"issue":"22","key":"2026022411372786800_bib27","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.3390\/ijms20225699","article-title":"miRNAs regulate cytokine secretion induced by phosphorylated S100A8\/A9 in neutrophils","volume":"20","author":"Jung","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1-2","key":"2026022411372786800_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-009-0126-1","article-title":"COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells","volume":"330","author":"Radilova","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2026022411372786800_bib29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCRESAHA.111.300539","article-title":"Circulating microRNAs as novel biomarkers for platelet activation","volume":"112","author":"Willeit","year":"2013","journal-title":"Circ Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1236\/2503917\/blooda_adv-2025-017653-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1236\/2503917\/blooda_adv-2025-017653-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:37:35Z","timestamp":1771951055000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/4\/1236\/548488\/Circulating-S100A8-A9-drives-faster-platelet-COX-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017653","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,24]]},"published":{"date-parts":[[2026,2,13]]}}}